The abstract is read at the publisher; the summary is JClub's.
The CACNA1A D1634N mutation causes CaV2.1 loss of function, with significantly reduced whole-cell current amplitude and a +25 mV shift in activation in heterologous expression.
- Why it matters: Treating CACNA1A-related neurological disease is limited by unknown mutation biophysics, incomplete links between genotype and channel/behavior, and few animal models that reflect patient phenotypes.
- What they did: The study combined heterologous expression, induced pluripotent stem cell–derived patient-specific cortical neurons, and heterozygous knock-in mice carrying the analogous D1585N mutation, plus Purkinje cell and cerebellar slice electrophysiology.
- The result: Patient-derived neurons showed enhanced intrinsic excitability, and D1585N knock-in mice exhibited ataxia, absence epilepsy, and cognitive deficits, supported by reduced CaV2.1 current, altered Purkinje excitability, and presynaptic vesicle release changes.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.